Blood screening by nucleic acid amplification technology: Current issues, future challenges

Molecular Diagnosis

Volumn 5, Issue 1, 2000, Pages 11-22

  Gallarda, James L ^a  

^a ROCHE MOLECULAR SYSTEMS   (United States)

Author keywords

Blood screening; HCV; HIV; Polymerase chain reaction; Transcription mediated amplification

Indexed keywords

BLOOD TRANSFUSION; ENZYME IMMUNOASSAY; GENE AMPLIFICATION; HEPATITIS C; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; INFECTION; POLYMERASE CHAIN REACTION; REVIEW; SEROCONVERSION;

EID: 0034018648     PISSN: 10848592     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1084-8592(00)00006-0     Document Type: Article

References (4)

1. Centers for Disease Control: Update on acquired immunodeficiency syndrome (AIDS) among patients with hemophilia A. Morb Mortal Wkly Rep 1982; 31:644-651
2. Beeson PB: Jaundice occurring one to four months after transfusion of blood or plasma. Report of seven cases. JAMA 1943;121:1332-1334
3. Hewlett IK, Epstein JS: Food and Drug Administration conference on the feasibility of genetic technology to close the HIV window in donor screening (conference report). Transfusion 1997;37:346-351
4. Gallarda JL, Henrard DR, Liu D, et al.: Early detection of antibody to human immunodeficiency virus type 1 by an antigen conjugate immunoassay correlates with the presence of IgM antibody. J Clin Microbiol 1992;30:770-772